Quantum Biopharma (QNTM) Minority Interest (2023 - 2026)

Quantum Biopharma has disclosed Minority Interest across 4 years of filings, most recently posting -$2.0 million for Q1 2026.

• Minority Interest for Q1 2026 came in at -$2.0 million, down 67.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 67.44% YoY), and the FY2025 annual result was -$1.8 million, down 75.13% from the prior year.
• Minority Interest came in at -$2.0 million for Q1 2026 at Quantum Biopharma, down from -$1.8 million in the prior quarter.
• In the past five years, Minority Interest ranged from a high of $571429.0 in Q3 2025 to a low of -$2.0 million in Q1 2026.
• The 4-year median for Minority Interest is -$850212.5 (2024), against an average of -$816374.5.
• Across the five-year window, Minority Interest plunged 954.77% in 2024 and surged 160.51% in 2025, its largest moves.
• Quantum Biopharma's Minority Interest stood at -$89526.0 in 2023, then tumbled by 1062.02% to -$1.0 million in 2024, then tumbled by 75.13% to -$1.8 million in 2025, then slipped by 10.61% to -$2.0 million in 2026.
• The last three Minority Interest figures came in at -$2.0 million (Q1 2026), -$1.8 million (Q4 2025), and $571429.0 (Q3 2025), per Business Quant data.